Literature DB >> 18188933

In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation.

Dibyendu Chakraborty1, Patrick Whalen, Alfred S Lewin, Muna I Naash.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18188933      PMCID： PMC2793173          DOI： 10.1007/978-0-387-74904-4_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  40 in total

Review 1.  Retinitis pigmentosa.

Authors:  Dyonne T Hartong; Eliot L Berson; Thaddeus P Dryja
Journal:  Lancet       Date:  2006-11-18       Impact factor: 79.321

2.  Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa.

Authors:  C H Sung; B G Schneider; N Agarwal; D S Papermaster; J Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa.

Authors:  Beatrice M Tam; Orson L Moritz
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

4.  Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.

Authors:  Jianwen Liu; Adrian M Timmers; Alfred S Lewin; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

5.  Optimization of an anti-HIV hairpin ribozyme by in vitro selection.

Authors:  S Joseph; J M Burke
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

6.  Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference.

Authors:  S M Cashman; E A Binkley; R Kumar-Singh
Journal:  Gene Ther       Date:  2005-08       Impact factor: 5.250

7.  Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain.

Authors:  C H Sung; C M Davenport; J Nathans
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

8.  Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene.

Authors:  M I Naash; J G Hollyfield; M R al-Ubaidi; W Baehr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa.

Authors:  T P Dryja; L B Hahn; G S Cowley; T L McGee; E L Berson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 10.  RNAi therapeutics: a potential new class of pharmaceutical drugs.

Authors:  David Bumcrot; Muthiah Manoharan; Victor Koteliansky; Dinah W Y Sah
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040
View more
  3 in total

Review 1.  Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-28       Impact factor: 6.915

2.  Wild-type opsin does not aggregate with a misfolded opsin mutant.

Authors:  Megan Gragg; Tae Gyun Kim; Scott Howell; P S-H Park
Journal:  Biochim Biophys Acta       Date:  2016-04-23

Review 3.  Gene therapy in animal models of autosomal dominant retinitis pigmentosa.

Authors:  Brian Rossmiller; Haoyu Mao; Alfred S Lewin
Journal:  Mol Vis       Date:  2012-10-06       Impact factor: 2.367
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.